Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas/Fas Ligand pathway

Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas/Fas Ligand pathway

<p>Abstract</p> <p>Background</p> <p>The lack of effective treatments for gliomas makes them a significant health problem and highlights the need for the development of novel and innovative treatment approaches. Immunotherapy is an appealing strategy because of the pote...

Full description

Bibliographic Details
Main Authors: Konkankit Veerauo V, Kim Won, Koya Richard C, Eskin Ascia, Dam Mai-Anh, Nelson Stanley, Ribas Antoni, Liau Linda M, Prins Robert M
Format: Article
Language:English
Published: BMC 2011-11-01
Series:Journal of Translational Medicine
Subjects:
T cells
tumor immunity
decitabine
cancer testis antigens
Fas/Fas Ligand
Online Access:http://www.translational-medicine.com/content/9/1/192

Internet

http://www.translational-medicine.com/content/9/1/192

Similar Items